12th pharmacovigilance stakeholder forum

• Date:
  Monday, 24 September 2018, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and the pharmaceutical industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Video

Documents

Agenda – 12th Pharmacovigilance stakeholder forum

Reference Number: EMA/274125/2018

List of participants: 12th stakeholder forum on the pharmacovigilance legislation

Reference Number: EMA/505196/2018

Presentation - Pharmacovigilance in 2018 (P. Arlett)

Presentation - Overview of current patient involvement (M. Mavris)

Presentation - Public Hearings; experience so far (N. Bere)

Presentation - The engagement of patients and healthcare professionals in regulatory pharmacovigilance: developing a conceptualisation (P. Brown)

Presentation - Valproate case study: industry perspective (E. Teo)

Presentation - Public hearing on valproate: Account of events and outcomes (E. Vatzaki)

Presentation - Valproate case study: patients' perspective (F.Houyez)

Presentation - Valproate case study: pharmacists' perspective (R. Anderson)

Presentation - Valproate case study: doctors' perspective (R. Kalvianen)

Presentation - Valproate case study: engagement of patients and healthcare professionals (P. Bahri)

Presentation - Pharmacovigilance in the next 5 years, doctors' vision (C. Matias)

Presentation - Pharmacovigilance in the next 5 years, pharmacists' vision (J. De Belie)

Presentation - Pharmacovigilance in the next 5 years, industry vision (V. Edwards)